These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8623150)

  • 1. Thrombin inhibition in an ex vivo model of porcine heart xenograft hyperacute rejection.
    Robson SC; Young VK; Cook NS; Metternich R; Kasper-Konig W; Lesnikoski BA; Pierson RN; Hancock WW; Candinas D; White DJ; Bach FH
    Transplantation; 1996 Mar; 61(6):862-8. PubMed ID: 8623150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of hyperacute xenograft rejection through direct thrombin inhibition with hirudin.
    Brenner P; Keller M; Beiras-Fernandez A; Uchita S; Kur F; Thein E; Wimmer C; Hammer C; Schmoeckel M; Reichart B
    Ann Transplant; 2010; 15(4):30-7. PubMed ID: 21183873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation.
    Kroshus TJ; Rollins SA; Dalmasso AP; Elliott EA; Matis LA; Squinto SP; Bolman RM
    Transplantation; 1995 Dec; 60(11):1194-202. PubMed ID: 8525509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement dependent early immunological responses during ex vivo xenoperfusion of hCD46/HLA-E double transgenic pig forelimbs with human blood.
    Bongoni AK; Kiermeir D; Jenni H; Bähr A; Ayares D; Klymiuk N; Wolf E; Voegelin E; Constantinescu MA; Seebach JD; Rieben R
    Xenotransplantation; 2014; 21(3):230-43. PubMed ID: 24635052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of ischemic time on hyperacute xenograft rejection of pig hearts in a working heart perfusion model with human blood.
    Brenner P; Hinz M; Huber H; Schmoeckel M; Reichenspurner H; Meiser B; Hammer C; Reichart B
    Transpl Int; 2000; 13 Suppl 1():S494-503. PubMed ID: 11112061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective IgM depletion prolongs organ survival in an ex vivo model of pig-to-human xenotransplantation.
    Kroshus TJ; Bolman RM; Dalmasso AP
    Transplantation; 1996 Jul; 62(1):5-12. PubMed ID: 8693544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo characterization of human anti-porcine hyperacute cardiac rejection.
    Kirk AD; Heinle JS; Mault JR; Sanfilippo F
    Transplantation; 1993 Oct; 56(4):785-93. PubMed ID: 8212196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new in vitro model for the study of pig-to-human vascular hyperacute rejection.
    Bennet W; Sundberg B; Elgue G; Larsson R; Korsgren O; Nilsson B
    Xenotransplantation; 2001 Aug; 8(3):176-84. PubMed ID: 11472625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining the hDAF transgene with the GP IIb/IIIa inhibitor tirofiban improves heart performance and reduces myocardial damage following hyperacute rejection in an ex vivo perfusion model.
    Brandl U; Erhardt M; Joeckle H; Michel S; Brenner P; Bittmann I; Roessle M; Mordstein V; Hammer C; Schmoeckel M; Reichart B
    Transplant Proc; 2005; 37(1):491-2. PubMed ID: 15808686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porcine heart xenograft function and hyperacute rejection: the role of thrombin inhibition.
    Uchita S; Thein E; Huber H; Wimmer C; Kur F; Brenner P; Hammer C
    Transplant Proc; 2001; 33(1-2):729-31. PubMed ID: 11267043
    [No Abstract]   [Full Text] [Related]  

  • 11. Aurintricarboxylic acid inhibits endothelial activation, complement activation, and von Willebrand factor secretion in vitro and attenuates hyperacute rejection in an ex vivo model of pig-to-human pulmonary xenotransplantation.
    Kim HK; Kim JE; Wi HC; Lee SW; Kim JY; Kang HJ; Kim YT
    Xenotransplantation; 2008; 15(4):246-56. PubMed ID: 18957047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of hyperacute rejection by human decay accelerating factor in xenogeneic perfused working hearts.
    Schmoeckel M; Nollert G; Shahmohammadi M; Young VK; Chavez G; Kasper-König W; White DJ; Müller-Höcker J; Arendt RM; Wilbert-Lampen U; Hammer C; Reichart B
    Transplantation; 1996 Sep; 62(6):729-34. PubMed ID: 8824468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the performance of pig hearts perfused with pig or human blood using an ex-vivo working heart model.
    Dunning JJ; Pierson RN; Braidley PC; White DJ; Wallwork J
    Eur J Cardiothorac Surg; 1994; 8(4):204-6. PubMed ID: 8031564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of antibody and complement removal with a Ig-Therasorb column in a xenogeneic working heart model.
    Brenner P; Hinz M; Huber H; Schmoeckel M; Reichenspurner H; Meiser B; Hammer C; Reichart B
    Eur J Cardiothorac Surg; 1999 May; 15(5):672-9. PubMed ID: 10386416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against hyperacute xenograft rejection of transgenic rat hearts expressing human decay accelerating factor (DAF) transplanted into primates.
    Charreau B; Ménoret S; Tesson L; Azimzadeh A; Audet M; Wolf P; Marquet R; Verbakel C; Ijzermans J; Cowan P; Pearse M; d'Apice A; Soulillou JP; Anegon I
    Mol Med; 1999 Sep; 5(9):617-30. PubMed ID: 10551903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody removal by column immunoabsorption prevents tissue injury in an ex vivo model of pig-to-human xenograft hyperacute rejection.
    Kroshus TJ; Dalmasso AP; Leventhal JR; John R; Matas AJ; Bolman RM
    J Surg Res; 1995 Jul; 59(1):43-50. PubMed ID: 7630135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunopathology of hyperacute xenograft rejection in a swine-to-primate model.
    Platt JL; Fischel RJ; Matas AJ; Reif SA; Bolman RM; Bach FH
    Transplantation; 1991 Aug; 52(2):214-20. PubMed ID: 1871792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of human anti-porcine "natural antibodies" recovered from ex vivo perfused hearts--predominance of IgM and IgG2.
    Ross JR; Kirk AD; Ibrahim SE; Howell DN; Baldwin WM; Sanfilippo FP
    Transplantation; 1993 May; 55(5):1144-50. PubMed ID: 8497896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pig analogue of CD59 protects transgenic mouse hearts from injury by human complement.
    Fisicaro N; Aminian A; Hinchliffe SJ; Morgan BP; Pearse MJ; D'Apice AJ; Cowan PJ
    Transplantation; 2000 Sep; 70(6):963-8. PubMed ID: 11014650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A technique for perfusion of an isolated working heart to investigate hyperacute discordant xenograft rejection.
    Forty J; White DG; Wallwork J
    J Thorac Cardiovasc Surg; 1993 Aug; 106(2):308-16. PubMed ID: 8341072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.